Literature DB >> 8002526

Effect of hyperoxia at 1 and 2 ATA on hypoxia and hypercapnia in human skin during experimental inflammation.

N C Abbot1, J S Beck, F M Carnochan, J H Gibbs, D K Harrison, P B James, J G Lowe.   

Abstract

Transcutaneous PO2 and PCO2 measurements and estimates of skin respiration were monitored at different levels of inspired PO2 in 20 healthy adults during the first 4 days of the tuberculin reaction, a convenient model of acute inflammation. Hyperoxia at 1 and 2 ATA significantly increased transcutaneous PO2 levels in undisturbed and in inflamed skin but did not fully correct the relative hypoxia at the site of inflammation. Hypercapnia was reduced with O2 breathing at 2 ATA. The apparent rate of O2 consumption at the reaction site was raised during hyperoxia, most prominently at 2 ATA. The most intense reactions showed a central relative slowing of laser-Doppler blood flow indicative of microcirculatory impairment. The extent of the relative hypoxia and hypercapnia was greatest in these strongest reactions. The density of lymphocytes and monocytes in biopsies of 48-h reactions was loosely related to the corresponding transcutaneous PO2 measurements. The present study provides evidence that diffusion barriers, in addition to increased local respiration, can contribute to the apparent hypoxia and hypercapnia of this inflammatory model.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8002526     DOI: 10.1152/jappl.1994.77.2.767

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  5 in total

Review 1.  Hyperbaric oxygen chambers and the treatment of sports injuries.

Authors:  J Staples; D Clement
Journal:  Sports Med       Date:  1996-10       Impact factor: 11.136

2.  Hypoxia in Leishmania major skin lesions impairs the NO-dependent leishmanicidal activity of macrophages.

Authors:  Alexander Mahnke; Robert J Meier; Valentin Schatz; Julian Hofmann; Kirstin Castiglione; Ulrike Schleicher; Otto S Wolfbeis; Christian Bogdan; Jonathan Jantsch
Journal:  J Invest Dermatol       Date:  2014-02-28       Impact factor: 8.551

3.  Hyperbaric oxygen treatment in autism spectrum disorders.

Authors:  Daniel A Rossignol; James J Bradstreet; Kyle Van Dyke; Cindy Schneider; Stuart H Freedenfeld; Nancy O'Hara; Stephanie Cave; Julie A Buckley; Elizabeth A Mumper; Richard E Frye
Journal:  Med Gas Res       Date:  2012-06-15

4.  Hyperbaric oxygen treatment for inflammatory bowel disease: a systematic review and analysis.

Authors:  Daniel A Rossignol
Journal:  Med Gas Res       Date:  2012-03-15

5.  On barring the vascular gateway against severe COVID-19 disease.

Authors:  George Perdrizet; Lawrence E Hightower
Journal:  Cell Stress Chaperones       Date:  2020-09       Impact factor: 3.667

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.